Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Research
German program matches lost NIH grants with pharma funders
Researchers can submit their NIH grants into BioMed X's platform, where pharma giants like Roche and AbbVie can view and consider supporting them.
Darren Incorvaia
Apr 7, 2025 10:50am
Merck KGaA pays $85M for global rights to Abbisko's tumor drug
Apr 1, 2025 7:40am
Merck KGaA fails lupus trial arm, plans further development
Mar 6, 2025 7:25am
2024's top 10 clinical trial flops
Feb 18, 2025 3:00am
Merck KGaA’s MilliporeSigma acquires Dutch organoid maker
Dec 18, 2024 12:39pm
AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders
Dec 13, 2024 8:30am
